The Intestinal Microbiome in Nonalcoholic Fatty Liver Disease

Cytoscape: A software Environment for integrated models of biomolecular interaction networks

Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888 · see citing works

KEGG: Kyoto Encyclopedia of Genes and Genomes

Kanehisa, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.27 · Cited by 37,077 · see citing works

QIIME allows analysis of high-throughput community sequencing data

Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887 · see citing works

KEGG: Kyoto Encyclopedia of Genes and Genomes

Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., & Kanehisa, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.29 · Cited by 31,232 · see citing works

Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities

Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 20,966 · see citing works

Naive Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy

Wang, Q., Garrity, G. M., Tiedje, J. M., & Cole, J. R. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.00062-07 · Cited by 19,770 · see citing works

Metagenomic biomarker discovery and explanation

Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192 · see citing works

An obesity-associated gut microbiome with increased capacity for energy harvest

Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · see citing works

Structure, function and diversity of the healthy human microbiome

The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726 · see citing works

Design and validation of a histological scoring system for nonalcoholic fatty liver disease†

Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791 · see citing works

Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences

Langille, M. G. I., Zaneveld, J., Caporaso, J. G., McDonald, D., Knights, D., Reyes, J. A., Clemente, J. C., Burkepile, D. E., Vega Thurber, R. L., Knight, R., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2676 · Cited by 9,116 · see citing works

Human gut microbes associated with obesity

Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785 · see citing works

A core gut microbiome in obese and lean twins

Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823 · see citing works

Enterotypes of the human gut microbiome

MetaHIT Consortium (additional members), Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., Fernandes, G. R., Tap, J., Bruls, T., et al. (2011) · Nature · doi:10.1038/nature09944 · Cited by 7,548 · see citing works

Richness of human gut microbiome correlates with metabolic markers

Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.-M., Kennedy, S., et al. (2013) · Nature · doi:10.1038/nature12506 · Cited by 4,662 · see citing works

Real-Time DNA Sequencing from Single Polymerase Molecules

Eid, J., Fehr, A., Gray, J., Luong, K., Lyle, J., Otto, G., Peluso, P., Rank, D., Baybayan, P., Bettman, B., et al. (2009) · Science · doi:10.1126/science.1162986 · Cited by 3,732 · see citing works

The Human Intestinal Microbiome in Health and Disease

Lynch, S. V., & Pedersen, O. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1600266 · Cited by 3,637 · see citing works

Immunological and inflammatory functions of the interleukin-1 family

Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466 · see citing works

Diet-Induced Obesity Is Linked to Marked but Reversible Alterations in the Mouse Distal Gut Microbiome

Turnbaugh, P. J., Bäckhed, F., Fulton, L., & Gordon, J. I. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.02.015 · Cited by 2,915 · see citing works

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078 · see citing works

TLR4 enhances TGF-β signaling and hepatic fibrosis

Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942 · see citing works

TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis

Thomas, C., Gioiello, A., Noriega, L., Strehle, A., Oury, J., Rizzo, G., Macchiarulo, A., Yamamoto, H., Mataki, C., Pruzanski, M., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.08.001 · Cited by 1,885 · see citing works

Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH

Zhu, L., Baker, S. S., Gill, C., Liu, W., Alkhouri, R., Baker, R. D., & Gill, S. R. (2013) · Hepatology · doi:10.1002/hep.26093 · Cited by 1,708 · see citing works

Statistical Methods for Detecting Differentially Abundant Features in Clinical Metagenomic Samples

White, J. R., Nagarajan, N., & Pop, M. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000352 · Cited by 1,581 · see citing works

The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota

Boursier, J., Mueller, O., Barret, M., Machado, M., Fizanne, L., Araujo‐Perez, F., Guy, C. D., Seed, P. C., Rawls, J. F., David, L. A., et al. (2016) · Hepatology · doi:10.1002/hep.28356 · Cited by 1,483 · see citing works

Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease

Loomba, R., Seguritan, V., Li, W., Long, T., Klitgord, N., Bhatt, A., Dulai, P. S., Caussy, C., Bettencourt, R., Highlander, S. K., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.001 · Cited by 1,123 · see citing works

Inflammation and Lipid Signaling in the Etiology of Insulin Resistance

Glass, C. K., & Olefsky, J. M. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.001 · Cited by 942 · see citing works

Intestinal microbiota in patients with nonalcoholic fatty liver disease

Mouzaki, M., Comelli, E. M., Arendt, B. M., Bonengel, J., Fung, S. K., Fischer, S. E., McGilvray, I. D., & Allard, J. P. (2013) · Hepatology · doi:10.1002/hep.26319 · Cited by 749 · see citing works

Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease

Raman, M., Ahmed, I., Gillevet, P. M., Probert, C. S., Ratcliffe, N. M., Smith, S., Greenwood, R., Sikaroodi, M., Lam, V., Crotty, P., et al. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.02.015 · Cited by 672 · see citing works

<scp>TGF</scp>‐β signalling and liver disease

Fabregat, I., Moreno‐Càceres, J., Sánchez, A., Dooley, S., Dewidar, B., Giannelli, G., ten Dijke, P., & the IT‐LIVER Consortium (2016) · The FEBS Journal · doi:10.1111/febs.13665 · Cited by 600 · see citing works

Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency

Spencer, M. D., Hamp, T. J., Reid, R. W., Fischer, L. M., Zeisel, S. H., & Fodor, A. A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.11.049 · Cited by 593 · see citing works

The Role of Endoplasmic Reticulum in Hepatic Lipid Homeostasis and Stress Signaling

Fu, S., Watkins, S. M., & Hotamışlıgil, G. S. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.007 · Cited by 540 · see citing works

Metagenomic species profiling using universal phylogenetic marker genes

Sunagawa, S., Mende, D. R., Zeller, G., Izquierdo-Carrasco, F., Berger, S. A., Kultima, J. R., Coelho, L. P., Arumugam, M., Tap, J., Nielsen, H. B., et al. (2013) · Nature Methods · doi:10.1038/nmeth.2693 · Cited by 503 · see citing works

A Taxonomic Signature of Obesity in the Microbiome? Getting to the Guts of the Matter

Finucane, M. M., Sharpton, T. J., Laurent, T. J., & Pollard, K. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084689 · Cited by 321 · see citing works

Clostridium scindens: a human gut microbe with a high potential to convert glucocorticoids into androgens

Ridlon, J. M., Ikegawa, S., Alves, J. M. P., Zhou, B., Kobayashi, A., Iida, T., Mitamura, K., Tanabe, G., Serrano, M., De Guzman, A., et al. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m038869 · Cited by 319 · see citing works

Monocyte Chemotactic Protein–1 As A Chemoattractant for Human Hepatic Stellate Cells

Marra, F., Romanelli, R. G., Giannini, C., Failli, P., Pastacaldi, S., Arrighi, M. C., Pinzani, M., Laffi, G., Montalto, P., & Geñtilini, P. (1999) · Hepatology · doi:10.1002/hep.510290107 · Cited by 259 · see citing works

Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver disease

Sanyal, A. J. (2005) · Nature Clinical Practice Gastroenterology &amp; Hepatology · doi:10.1038/ncpgasthep0084 · Cited by 216 · see citing works

Library preparation methodology can influence genomic and functional predictions in human microbiome research

Jones, M. B., Highlander, S. K., Anderson, E. L., Li, W., Dayrit, M., Klitgord, N., Fabani, M. M., Seguritan, V., Green, J., Pride, D. T., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1519288112 · Cited by 204 · see citing works

Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study design

Friedman, S. L., Sanyal, A. J., Goodman, Z. D., Lefebvre, E. A., Gottwald, M. D., Fischer, L., & Ratziu, V. (2016) · Contemporary Clinical Trials · doi:10.1016/j.cct.2016.02.012 · Cited by 197 · see citing works

Human BAMBI Cooperates with Smad7 to Inhibit Transforming Growth Factor-β Signaling

Yan, X., Lin, Z., Chen, F., Zhao, X., Chen, H., Ning, Y., & Chen, Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.049304 · Cited by 144 · see citing works

Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet α Cells to Promote Glucose Homeostasis

Kumar, D. P., Asgharpour, A., Mirshahi, F., Park, S. H., Liu, S., Imai, Y., Nadler, J. L., Grider, J. R., Murthy, K. S., & Sanyal, A. J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.699504 · Cited by 144 · see citing works

Next-generation sequencing technologies and applications for human genetic history and forensics

Berglund, E., Kiialainen, A., & Syvänen, A. (2011) · Investigative Genetics · doi:10.1186/2041-2223-2-23 · Cited by 143 · see citing works

Lipopolysaccharide induces and activates the Nalp3 inflammasome in the liver

Ganz, M. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i43.4772 · Cited by 121 · see citing works

An Update on PYRIN Domain-Containing Pattern Recognition Receptors: From Immunity to Pathology

Ratsimandresy, R. A., Dorfleutner, A., & Stehlik, C. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00440 · Cited by 109 · see citing works

Both bone marrow‐derived and non‐bone marrow‐derived cells contribute to AIM 2 and NLRP 3 inflammasome activation in a MyD88‐dependent manner in dietary steatohepatitis

Csák, T., Pillai, A., Ganz, M., Lippai, D., Petrasek, J., Park, J., Kodys, K., Dolganiuc, A., Kurt‐Jones, E. A., & Szabó, G. (2014) · Liver International · doi:10.1111/liv.12537 · Cited by 91 · see citing works

Endotoxemia unrequired in the pathogenesis of pediatric nonalcoholic steatohepatitis

Yuan, J., Baker, S. S., Liu, W., Alkhouri, R. H., Baker, R. D., Xie, J., Ji, G., & Zhu, L. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12510 · Cited by 64 · see citing works

Network‐Based Modeling of the Human Gut Microbiome

Naqvi, A. S., Rangwala, H., Keshavarzian, A., & Gillevet, P. M. (2010) · Chemistry & Biodiversity · doi:10.1002/cbdv.200900324 · Cited by 60 · see citing works

Increased Plasma Levels of Asymmetric Dimethylarginine in Nonalcoholic Fatty Liver Disease: Relation with Insulin Resistance, Inflammation, and Liver Histology

Boğa, S., Alkım, H., Köksal, A. R., Bayram, M., Ozguven, M. B. Y., Ergün, M., Neijmann, S. T., Ozgon, G. O., & Alkım, C. (2015) · Journal of Investigative Medicine · doi:10.1097/jim.0000000000000230 · Cited by 21 · see citing works

Analysis of Multitag Pyrosequence Data from Human Cervical Lavage Samples

Naqvi, A. S., Rangwala, H., Spear, G. T., & Gillevet, P. M. (2010) · Chemistry & Biodiversity · doi:10.1002/cbdv.200900321 · Cited by 8 · see citing works

Mechanisms of NAFLD development and therapeutic strategies

Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M., & Sanyal, A. J. (2018) · Nature Medicine · doi:10.1038/s41591-018-0104-9 · Cited by 4,354 · see citing works

Past, present and future perspectives in nonalcoholic fatty liver disease

Sanyal, A. J. (2019) · Nature Reviews Gastroenterology &amp; Hepatology · doi:10.1038/s41575-019-0144-8 · Cited by 522 · see citing works

Novel therapeutic targets for cholestatic and fatty liver disease

Trauner, M., & Fuchs, C. D. (2022) · Gut · doi:10.1136/gutjnl-2021-324305 · Cited by 204 · see citing works

The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies

Meroni, M., Longo, M., & Dongiovanni, P. (2019) · Nutrients · doi:10.3390/nu11112642 · Cited by 146 · see citing works

Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?

Ciaula, A. D., Passarella, S., Shanmugam, H., Noviello, M., Bonfrate, L., Wang, D. Q. ‐., & Portincasa, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105375 · Cited by 133 · see citing works

Gut Microbiota’s Relationship with Liver Disease and Role in Hepatoprotection by Dietary Natural Products and Probiotics

Meng, X., Li, S., Li, Y., Gan, R., & Li, H. (2018) · Nutrients · doi:10.3390/nu10101457 · Cited by 117 · see citing works

Microbiome diurnal rhythmicity and its impact on host physiology and disease risk

Nobs, S. P., Tuganbaev, T., & Elinav, E. (2019) · EMBO Reports · doi:10.15252/embr.201847129 · Cited by 90 · see citing works

Dietary carbohydrates and fatty liver disease

Chiu, S., Mulligan, K. M., & Schwarz, J. (2018) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000469 · Cited by 72 · see citing works

Genetics of Nonalcoholic Fatty Liver Disease: From Pathogenesis to Therapeutics

Sookoian, S. C., & Pirola, C. J. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1679920 · Cited by 70 · see citing works

Gut microbiome features associated with liver fibrosis in Hispanics, a population at high risk for fatty liver disease

Kwan, S., Jiao, J., Joon, A. Y., Wei, P., Petty, L. E., Below, J. E., Daniel, C. R., Wu, X., Zhang, J., Jenq, R. R., et al. (2021) · Hepatology · doi:10.1002/hep.32197 · Cited by 64 · see citing works

Cholestasis induced by bile duct ligation promotes changes in the intestinal microbiome in mice

Cabrera-Rubio, R., Patterson, A. M., Cotter, P. D., & Beraza, N. (2019) · Scientific Reports · doi:10.1038/s41598-019-48784-z · Cited by 61 · see citing works

Lactobacillus plantarum Ameliorates High-Carbohydrate Diet-Induced Hepatic Lipid Accumulation and Oxidative Stress by Upregulating Uridine Synthesis

Xu, R., Wang, T., Ding, F.-F., Zhou, N., Qiao, F., Chen, L., Du, Z., & Zhang, M. (2022) · Antioxidants · doi:10.3390/antiox11071238 · Cited by 48 · see citing works

Effect of Probiotics Therapy on Nonalcoholic Fatty Liver Disease

Huang, Y., Wang, X., Zhang, L., Zheng, K., Xiong, J., Li, J., Cong, C., Gong, Z., & Mao, J. (2022) · Computational and Mathematical Methods in Medicine · doi:10.1155/2022/7888076 · Cited by 45 · see citing works

Nonalcoholic Steatohepatitis Drug Development Pipeline: An Update

Chew, N., Ng, C. H., Truong, E., Noureddin, M., & Kowdley, K. V. (2022) · Seminars in Liver Disease · doi:10.1055/a-1877-9656 · Cited by 43 · see citing works

Anti-NAFLD effect of defatted walnut powder extract in high fat diet-induced C57BL/6 mice by modulating the gut microbiota

Ren, S., Zhang, Q.-Z., Chen, M., Jiang, M., Zhou, Y., Xu, X.-J., Wang, D., Pan, Y., & Liu, X. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.113814 · Cited by 43 · see citing works

Toll-Like Receptors Recognize Intestinal Microbes in Liver Cirrhosis

Fan, Y., Li, Y., Chu, Y., Liu, J., Cui, L., & Zhang, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.608498 · Cited by 31 · see citing works

Genetics, Immunity and Nutrition Boost the Switching from NASH to HCC

Dongiovanni, P., Meroni, M., Longo, M., Fargion, S. R., & Fracanzani, A. L. (2021) · Biomedicines · doi:10.3390/biomedicines9111524 · Cited by 27 · see citing works

Protocols for Mitochondria as the Target of Pharmacological Therapy in the Context of Nonalcoholic Fatty Liver Disease (NAFLD)

Grattagliano, I., Ciaula, A. D., Baj, J., Molina‐Molina, E., Shanmugam, H., Garruti, G., Wang, D. Q. ‐., & Portincasa, P. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1433-4_12 · Cited by 26 · see citing works

Interactions between resveratrol and gut microbiota affect the development of hepatic steatosis: A fecal microbiota transplantation study in high-fat diet mice

Yin, X., Liao, W., Li, Q., Zhang, H., Liu, Z., Zheng, X., Lin, Z., & Feng, X. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.103883 · Cited by 25 · see citing works

The emerging role of the gut mycobiome in liver diseases

Szóstak, N., Figlerowicz, M., & Philips, A. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2211922 · Cited by 22 · see citing works

Nonalcoholic Steatohepatitis (NASH) and Atherosclerosis: Explaining Their Pathophysiology, Association and the Role of Incretin-Based Drugs

Galatou, E., Mourelatou, E. A., Hatziantoniou, S., & Vizirianakis, I. S. (2022) · Antioxidants · doi:10.3390/antiox11061060 · Cited by 17 · see citing works

Understanding crosstalk between the gut and liver microbiome: pathogenesis to therapeutic approaches in liver cancer

Goyal, H., Fatima, K., & Kaur, J. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03840-9 · Cited by 11 · see citing works

Post-hoc analysis of a randomized controlled trial on the impact of pre-transplant use of probiotics on outcomes after liver transplantation

Grąt, M., Grąt, K., Krawczyk, M., Lewandowski, Z., Krasnodębski, M., Masior, Ł., Patkowski, W., & Zieniewicz, K. (2020) · Scientific Reports · doi:10.1038/s41598-020-76994-3 · Cited by 10 · see citing works

Protection against fibrosis by a bacterial consortium in metabolic dysfunction-associated steatohepatitis and the role of amino acid metabolism

Kwan, S., Gonzales, K. A., Jamal, M. A., Stevenson, H. L., Tan, L., Lorenzi, P. L., Futreal, P. A., Hawk, E. T., McCormick, J. B., Fisher‐Hoch, S. P., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2399260 · Cited by 9 · see citing works

Gut phageome in Mexican Americans: a population at high risk for metabolic dysfunction-associated steatotic liver disease and diabetes

Kwan, S., Sabotta, C. M., Cruz, L. R., Wong, M. C., Ajami, N. J., McCormick, J. B., Fisher‐Hoch, S. P., & Beretta, L. (2024) · mSystems · doi:10.1128/msystems.00434-24 · Cited by 7 · see citing works

The Intestinal Microbiome, Plasma Metabolome, and Liver Transcriptome: A Conspiracy Driving Hepatic Steatosis

Mehal, W. Z., & Loomba, R. S. (2019) · Hepatology · doi:10.1002/hep.30577 · Cited by 7 · see citing works

Gut Microbiome and Hepatic Transcriptomic Determinants of HCC Development in Mice with Metabolic Dysfunction-Associated Steatohepatitis

Dolapchiev, L. I., Gonzales, K. A., Graham, L. C., Gagea, M., Stevenson, H. L., Kwan, S., & Beretta, L. (2024) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s485532 · Cited by 6 · see citing works

Recreating gut-liver axis during NAFLD onset by using a Caco-2/HepG2 co-culture system

Meroni, M., Paolini, E., Longo, M., Piciotti, R., Tria, G., Fargion, S. R., Fracanzani, A. L., & Dongiovanni, P. (2022) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2021.19 · Cited by 4 · see citing works

Blood bacterial DNA signatures in a prospective cohort of patients with MASLD cirrhosis

Kwan, S., Dolapchiev, L. I., Sanchez, C. I., Calderone, T. L., Sanchez, J. I., Bhongade, M. B., Sabagh, A. E., Cleere, D. W., Gupta, N., Jalal, P. K., et al. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000722 · Cited by 2 · see citing works

Progressive dysfunction of the immune system as a factor preventing recoverable regeneration of the liver in chronic fibrosing diseases

Онищенко, Н. А., Nikolskaya, A. O., & Шагидулин, М. Ю. (2023) · Zhurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia» · doi:10.25557/0031-2991.2023.03.109-123 · Cited by 1 · see citing works

The Gut Microbiome

Francella, C., & Foster, J. A. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc297

Marqueurs diagnostiques et pronostiques de la stéatohépatite métabolique

Coilly, A. (2019) · doi:10.70675/488abf31z3acfz4f13z88e2zd974ef8b9b7b

Mapping the genomic landscape of MASLD: A framework for molecular subtyping and precision hepatology

Pirola, C. J., & Sookoian, S. C. (2026) · Med · doi:10.1016/j.medj.2026.101131

About the role of intestinal microbiota in the pathogenesis and treatment of non-alcoholic fatty liver disease

Khalilova, D., & Sahautdinova, G. M. (2024) · Лечащий врач · doi:10.51793/os.2024.27.5.009 · Cited by 2 · see citing works

Non-alcoholic fatty liver disease in the context of the gut microbiome

Gridnyev, O., & Дубров, К. Ю. (2019) · Modern Gastroenterology · doi:10.30978/mg-2019-5-97

REVIEW ARTICLE The gut microbiota of nonalcoholic fatty liver disease: current methods and their interpretation

Rensen, E. S. (2016)

The gut microbiota of nonalcoholic fatty liver disease: current methods and their interpretation

van Best, N., Jansen, P. L. M., & Rensen, S. S. (2015) · Hepatology International · doi:10.1007/s12072-015-9640-2 · Cited by 36 · see citing works

Role of intestinal microbiota in the formation of non-alcoholic fatty liver disease

Ахмедов, В. А., & Gaus, O. V. (2019) · Terapevticheskii arkhiv · doi:10.26442/00403660.2019.02.000051 · Cited by 10 · see citing works